DGX

227.86

0.02% -0.04

Dopo l'orario di chiusura: 227.86

Quest Diagnostics Inc (DGX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$227.90

Aprire:

$228

Volume 24 ore:

1.54M

Relative Volume:

1.62

Capitalizzazione di mercato:

$25.15B

Reddito:

$11.28B

Utile/perdita netta:

$1.07B

Rapporto P/E:

25.13

EPS:

9.0657

Flusso di cassa netto:

$1.33B

1 W Prestazione:

+8.15%

1M Prestazione:

+12.19%

6M Prestazione:

+25.88%

1 anno Prestazione:

+32.55%

Intervallo 1D:

$223.42

$233.21

Intervallo di 1 settimana:

$204.10

$237.78

Portata 52W:

$165.78

$237.78

Quest Diagnostics Inc Stock (DGX) Company Profile

Nome

Quest Diagnostics Inc

Settore

Healthcare (1071)

Industria

Diagnostics & Research (48)

Telefono

(973) 520-2700

Indirizzo

500 PLAZA DRIVE, SECAUCUS

Dipendente

57,000

Cinguettio

@QuestDX

Prossima data di guadagno

2026-07-23

Ultimi documenti SEC

DGX's Discussions on Twitter

Compare DGX vs TMO, DHR, IDXX, A, NTRA

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DGX Quest Diagnostics Inc	227.86	25.15B	11.28B	1.07B	1.33B	9.0657
TMO Thermo Fisher Scientific Inc	568.26	211.18B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	191.50	134.62B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	544.32	42.94B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	138.57	39.14B	7.23B	1.41B	1.09B	4.979
NTRA Natera Inc	261.99	37.52B	2.50B	-226.32M	71.51M	-1.6412

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-30	Aggiornamento	Barclays	Equal Weight → Overweight
2025-08-25	Downgrade	Robert W. Baird	Outperform → Neutral
2025-04-02	Iniziato	Redburn Atlantic	Buy
2025-03-04	Downgrade	Citigroup	Buy → Neutral
2025-01-06	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-12-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	Ripresa	Jefferies	Buy
2024-10-23	Aggiornamento	Robert W. Baird	Neutral → Outperform
2024-08-28	Ripresa	Evercore ISI	In-line
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-02-26	Iniziato	Leerink Partners	Market Perform
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2024-01-03	Iniziato	Barclays	Equal Weight
2023-12-12	Aggiornamento	BofA Securities	Neutral → Buy
2023-06-29	Iniziato	Piper Sandler	Neutral
2023-05-02	Downgrade	BofA Securities	Buy → Neutral
2023-04-03	Aggiornamento	Citigroup	Sell → Neutral
2023-01-23	Iniziato	Evercore ISI	In-line
2022-11-17	Downgrade	Citigroup	Neutral → Sell
2022-08-22	Ripresa	Morgan Stanley	Equal-Weight
2022-04-04	Downgrade	Citigroup	Buy → Neutral
2022-02-23	Downgrade	UBS	Buy → Neutral
2022-02-02	Downgrade	Jefferies	Buy → Hold
2022-01-28	Downgrade	Deutsche Bank	Buy → Hold
2021-05-04	Aggiornamento	UBS	Neutral → Buy
2021-03-12	Downgrade	Robert W. Baird	Outperform → Neutral
2020-10-21	Aggiornamento	Argus	Hold → Buy
2020-07-29	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Aggiornamento	BofA Securities	Neutral → Buy
2020-06-09	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2020-06-02	Aggiornamento	Deutsche Bank	Hold → Buy
2020-04-28	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Aggiornamento	Citigroup	Neutral → Buy
2020-04-27	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2020-03-27	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Downgrade	Barclays	Overweight → Equal Weight
2019-12-19	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-07-15	Downgrade	Goldman	Neutral → Sell
2019-04-02	Aggiornamento	Jefferies	Hold → Buy
2019-03-18	Ripresa	Credit Suisse	Neutral
2019-01-31	Downgrade	Argus	Buy → Hold
2019-01-17	Iniziato	UBS	Neutral
2019-01-03	Downgrade	BofA/Merrill	Neutral → Underperform
2018-12-03	Downgrade	BofA/Merrill	Buy → Neutral
2018-11-30	Downgrade	Goldman	Buy → Neutral

Mostra tutto

Quest Diagnostics Inc Borsa (DGX) Ultime notizie

07:03 AM